Skip to content

10x Genomics, Inc. TXG Change in Other Assets

Change in Other Assets at other companies

Illumina logo
IlluminaILMN
$26M+2,500%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$641K+141%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$2.03M-65.0%
Repligen logo
RepligenRGEN
-$26K-102%
Danaher logo
DanaherDHR
$40M+25.0%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
-$77K-128%

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%
Enterprise value$4B+199%
P/S6.9×+4.1×

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s change in other assets?
10x Genomics, Inc. (TXG) reported change in other assets of -$1.95M in Q1 2026.
How has 10x Genomics, Inc.'s change in other assets changed year-over-year?
10x Genomics, Inc.'s change in other assets decreased by 135.2% year-over-year, from $5.53M to -$1.95M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.